Defining the minimally effective dose and schedule for parenteral hydrogen sulfide: long-term benefits in a rat model of hindlimb ischemia
Crossref DOI link: https://doi.org/10.1186/s13618-015-0027-1
Published Online: 2015-04-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Langston, John William
Toombs, Christopher F
License valid from 2015-04-16